McGill University

McGill University

McGill University

Date Founded



3520 University Street, Montreal, Quebec, H3A 2A7, Canada

Charitable Causes

Higher Education & Universities
Education Research & Support

Company Description

McGill University is a public research university located in Montreal, Quebec, Canada. Founded in 1821 during the British colonial era, the university bears the name of James McGill, a prominent Montreal merchant from Glasgow, Scotland and alumnus of Glasgow University, whose bequest formed the beginning of the university.

Executives & Employees


Executive Director, Internal Audit

Executive Director, Planning & Institutional Analysis

Treasurer/Executive Director, Investments

Executive Director

Chief Investment Officer

General Counsel & Director of Legal Services


President-Alumni Club of Northern California

Dean, Desautels Faculty of Management

Board of Directors

Director-Emeritus at The Canadian Institute for Advanced Research

Former President & Chief Executive Officer at CN Investment Division

Distinguished Alumni
Paul Desmarais, Jr. is now Executive Chairman of the Board & Co-Chief Executive Officer at Pargesa Holding SA
Mirko Bibic is now President, Chief Executive Officer & Director at BCE Inc.
Ngit Liong Wong is now Chairman & Chief Executive Officer at Venture Corp. Ltd.
Paths to McGill University
Potential Connections via
Relationship Science
McGill University
Recent Transactions
Details Hidden

Queen’s University, Neuroceptor, Inc. purchase Antalium, Inc. from McGill University

Details Hidden

McGill University purchases Renaissance Montreal Hotel from Barings Real Estate Advisers LLC

Advisors & Consultants

Principal at Kathleen Loehr & Associates


Former Executive Director, Development at California Institute of the Arts - Valencia


Former Vice President & Director at The Clowes Fund Incorporated


Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer. It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Global Supply Chain Platform segment provides supply of active pharmaceutical ingredients (APIs) for clinical and commercial efforts. The Commercial Platform segment involves the sale and marketing of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.

Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Details Hidden

Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA.

Details Hidden

MOXXI Medical, Inc. develops electronic prescribing and computerized drug management systems. It develops in the fields of information and communication technologies to create an integrated delivery system for drug management. The company was founded in September 2003 and is headquartered in Montréal, Canada.

Hamilton Thorne Ltd. Biotechnology | Beverly, Massachusetts

Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. Its brands include Hamilton Thorne, Embryotech, and Gynemed. The company was founded by Meg Spencer and Diarmaid H. Douglas-Hamilton on October 28, 2009 and is headquartered in Beverly, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by McGill University. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of McGill University's profile does not indicate a business or promotional relationship of any kind between RelSci and McGill University.